Dr.Inas Al-Samadi Dr. Inas Al-Samadi
About me
Dr. Al Samadi’s work aligns closely with the United Nations Sustainable Development Goals (SDGs), particularly SDG 3: Good Health and Well-being, SDG 4: Quality Education, and SDG 9: Industry, Innovation and Infrastructure. Through her research in advanced drug delivery systems, nanotechnology, and biopharmaceutics, she contributes to improving the safety, efficacy, and accessibility of therapeutic interventions, supporting global health outcomes. Her commitment to academic excellence and student mentorship promotes inclusive and high-quality education, while her engagement in quality assurance and Six Sigma implementation enhances innovation, efficiency, and sustainability within pharmaceutical systems. Additionally, her involvement in community service and scientific capacity-building initiatives reflects a broader dedication to strengthening research ecosystems and supporting evidence-based solutions to public health and industrial challenges.
Dr. Inas Al Samadi is a Lecturer in the Industrial Pharmacy Department at the College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), Cairo, Egypt.
She earned her Bachelor of Pharmaceutical Sciences (B.Sc.) from MUST and further advanced her academic and professional qualifications through diplomas in Statistical Control and Quality Assurance from Cairo University, as well as Lean Six Sigma and Statistical Research from Ain Shams University. She completed both her Master of Science (M.Sc.) and Doctor of Philosophy (Ph.D.) in Pharmaceutics and Industrial Pharmacy at the Faculty of Pharmacy, Cairo University.
Dr. Al Samadi’s research interests encompass industrial pharmacy, Six Sigma implementation in pharmaceutical systems, biostatistics and advanced statistical analysis, formulation development and characterization, conventional and novel dosage forms, controlled drug delivery, biopharmaceutics, nanotechnology, and targeted drug delivery systems. Her work focuses on the development and evaluation of innovative and efficient drug delivery platforms.
She has extensive experience in teaching and research within pharmaceutics and industrial pharmacy and has published in reputable national and international journals. In addition to her academic contributions, she serves as an Associate Editor at the Journal of Pharmaceutical Sciences and Drug Manufacturing (JPSDM), reflecting her active role in advancing scientific research and publication quality.
Dr. Al Samadi holds several academic and administrative roles at MUST, including serving as Vice Manager of the Quality Assurance Unit and contributing to institutional development and academic excellence. She is actively involved in community service and academic activities through her role in the Community Service and Environmental Development sector, as well as her membership in the College of Pharmacy (COP) Webinar and Conference Committee.
She also plays a key role in student development and research innovation, serving as an Academic Advisor and as a member of the management board of the Student Experimental Factory (SEF-MUST). Additionally, she is a member of the Student Research Center and has contributed to mentoring and evaluating student research projects.
Her academic career includes progressive experience as an Assistant Lecturer and Research Pharmacist at MUST, demonstrating a strong foundation in both education and applied pharmaceutical research.
Dr. Al Samadi actively participates in the global scientific community through conference attendance, research presentations, and organizational roles in major scientific events, including AAPS and Pharmaconex, as well as contributing to the organization of international scientific conferences.
Degrees:
TM El-Nawawy, YA Adel, M Teaima, NN Nassar, AA Nemr, I Al-Samadi, et al.
Pharmaceutical Development and Technology, 29(7), 663–674.
2025 – Optimized Hesperidin-Loaded Lipid Nanoparticles with Tea Tree Oil for Enhanced Wound Healing: Formulation, Characterization, and Evaluation
B Arneth, R Abdelmonem, MA El-Nabarawi, MH Teaima, KO Rashwan, I Al-Samadi, et al.
Pharmaceuticals, 18(3), 290.
2021 – Formulation and Evaluation of Baclofen–Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODT Performance Using Six Sigma Method
R Abdelmonem, MM Abdellatif, IEI Al-Samadi, MA El-Nabarawi.
Drug Design, Development and Therapy, 4383–4402.
2022 – Fabrication of Nanostructured Lipid Carriers Ocugel for Enhancing Loratadine Used in Treatment of COVID-19-Related Symptoms: Statistical Optimization, In Vitro, Ex Vivo, and In Vivo Evaluation
R Abdelmonem, IEI Al-Samadi, RM El Nashar, BR Jasti, MA El-Nabarawi.
Drug Delivery, 29(1), 2868–2882.
2025 – Formulation, Optimisation, and Evaluation of Lornoxicam-Loaded Novasomes for Targeted Ulcerative Colitis Therapy: In Vitro and In Vivo Investigations
ABD Abeer Salama, Inas Essam Ibrahim Al-Samadi.
Journal of Drug Targeting, 1–21.
2025 – Dual-Action of Clotrimazole-Loaded Nanosponges Vaginal Gel for Spermicidal Action and Treatment of Vaginal Candidiasis: Optimization, In Vitro, Ex Vivo, and In Vivo Experiments
DA Helal, A Osama, MA El-Nabarawi, MH Teaima, IEI Al-Samadi.
International Journal of Pharmaceutics, 670, 125193.
2025 – Comparative Study of Transdermal and Intranasal Delivery of Escitalopram/SPIONs-Loaded Transinvasomes: A Magnetoresponsive Nanocarrier for Enhanced Brain Targeting in Depression Therapy
SM Ahmed, IEI Al-Samadi, M Teaima, MA El-Nabarawi, MM Abdellatif.
Journal of Drug Delivery Science and Technology, 107678.
2025 – Topical Loratadine-Loaded Invasomal Gel Repurposed for Vulvovaginal Candidiasis: In Vitro, In Silico, Ex Vivo, and In Vivo Studies
IEI Al-Samadi, KO Rashwan, R Abdelmonem, MIA Hamed, KM Darwish, et al.
International Journal of Pharmaceutics, 677, 125639.